Clinical Trial Update: A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating KQB365 as monotherapy and in combination for advanced solid malignancies, including colorectal cancer, is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• KQB365

Snippet

Sponsor: Kumquat Biosciences Inc. | Conditions: KRAS G12C Mutation, KRAS G12S Mutation | Phase 1 | Status: RECRUITING